(HKSE:6855),(NasdaqGM:AAPG), ROCKVILLE, Md. and SUZHOU, China, Nov. 03, 2025 (GLOBE NEWSWIRE) — Ascentage Pharma Group International Inc. (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced that the latest results from multiple clinical studies […]

Ascentage Pharma to Present Data from Two Clinical Studies for Bcl-2 Inhibitor Lisaftoclax, Including an Oral Report, at ASH 2025 GlobeNewswire November 04, 2025 ROCKVILLE, Md. and SUZHOU, China, Nov. 03, 2025 (GLOBE NEWSWIRE) — Ascentage Pharma Group International Inc. (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery,

Ascentage Pharma to Present Data from Multiple Studies of Olverembatinib, Including the First Dataset from POLARIS-1 Study, at ASH 2025 GlobeNewswire November 04, 2025 ROCKVILLE, Md. and SUZHOU, China, Nov. 03, 2025 (GLOBE NEWSWIRE) — Ascentage Pharma Group International Inc. (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery,

COSTA MESA, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) — Nitto Tire U.S.A. Inc. proudly announces that advisor and former Chairman and CEO Tomoshige “Tomo” Mizutani has been inducted into the Tire Industry Hall of Fame, one of the highest honors in the tire business. The induction will be celebrated in Las Vegas hosted by the

Tomo Mizutani Honored with Tire Industry Hall of Fame Induction for Four Decades of Innovation and Leadership GlobeNewswire November 04, 2025 COSTA MESA, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) — Nitto Tire U.S.A. Inc. proudly announces that advisor and former Chairman and CEO Tomoshige “Tomo” Mizutani has been inducted into the Tire Industry Hall of

(NASDAQ:SNPS), NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) — Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of all persons or entities who purchased or otherwise acquired Synopsys, Inc. (“Synopsys” or the “Company”) (NASDAQ: SNPS)

Durham, NC and Los Baños, Philippines, Nov. 03, 2025 (GLOBE NEWSWIRE) — Pairwise has licensed its Fulcrum(R) gene editing platform to the International Rice Research Institute (IRRI), a non-profit agricultural research organization. The agreement will enable IRRI to apply CRISPR technology to develop rice varieties with higher yields, greater climate resilience, and enhanced nutritional value,

Ultra-slim, rugged, and ready for seamless industrial automation KEY POINTS — Ultra-slim durability: Fanless, IP66-rated design with space-saving narrow bezels for industrial reliability and readiness — Efficient power: Intel® Core™ Ultra processors with up to 50%-better graphics and 20%-lower power use for stable 24/7 operation — Industrial versatility: Three panel sizes, each with four LAN

NEW YORK CITY, NY / ACCESS Newswire / November 3, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed on behalf of investors in the securities of Spirit Aviation Holdings, Inc. ("Spirit" or the "Company") (OTCMKTS:FLYYQ).�� The class action, filed in the United States District Court for the Southern District of

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Synopsys, Inc. (SNPS) GlobeNewswire November 04, 2025 NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) — Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California on